Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FOTIVDA safely and effectively. See full prescribing information for FOTIVDA. FOTIVDA ®(tivozanib) capsules, for oral use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
FOTIVDA is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
- generic_name
- tivozanib
- product_names
- Tivozanib
- ndc
- 45629-089, 45629-089-01, 45629-089-02, 45629-134, 45629-134-01, 45629-134-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en